By Christian Moess Laursen CeLsius Resources hasn’t yet received a mineral-production sharing agreement for its gold-copper project in the Philippines, which was expected Aug....
Introduction Zymeworks (NASDAQ:ZYME) is a biotech firm dedicated to crafting novel, multifunctional biotherapeutics, especially for challenging cancers and diseases. Their primary product, zanidatamab, is...